Status:
UNKNOWN
OCT Angiography in the Glaucoma Diagnosis
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Glaucoma is a chronic degenerative disease of the optic nerve. It is the second cause of blindness worldwide and a frequent cause of irreversible blindness. In 2020, epidemic health authorities have p...
Detailed Description
The OCT Angiography (OCTA) is a non-invasive technology, marketed since 2014, that uses OCT with infrared light, with no radiation nor side effects, to evaluate within seconds the vascularization of t...
Eligibility Criteria
Inclusion
- Patient whose age ≥ 18 years
- Patient consultant in the ophthalmology department of the Marie-Thérèse Health Center or the Polyclinique de la Baie
- French speaking patient
- Patient affiliated to a health insurance plan
- Patient having given free, informed and express consent
Exclusion
- Patient with another ophthalmological pathology or a history of ophthalmological pathology
- Patient with a history of ophthalmic surgery except for uncomplicated cataract surgery
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Pregnant or lactating woman
Key Trial Info
Start Date :
July 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04437446
Start Date
July 21 2020
End Date
December 31 2023
Last Update
April 27 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014
2
Polyclinique de la Baie
Saint-Martin-des-Champs, France, 50300